Discover
SILO
Silo Pharma, Inc.
6.17
2 x 4.59
2 x 7.74
bid
ask
-
0.04
0.56%
2 @ 04:00 PM
6.14 -0.03 (0.54%)
| Ytd | 20.98% | |
| 1y | -33.01% |
6.00
day range
6.57
3.31
52 week range
15.15
| Open | 6.04 | Prev Close | 6.21 | Low | 6.00 | High | 6.57 | Mkt Cap | 6.69M |
| Vol | 65.72K | Avg Vol | 294.49K | EPS | -5.85 | P/E | N/A | Forward P/E | -1.26 |
| Beta | 1.36 | Short Ratio | 0.98 | Inst. Own | 2.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 6.31 | 200-d Avg | 6.63 | 1yr Est | 10.00 |
SILO News
benzinga.com
Silo Pharma Engages Drug-Device Development Partner Resyca To Carry Out Trial To Evaluate Nasal Spra
Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-sta
globenewswire.com
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA
Study designed to evaluate performance and formulation stability of proprietary nose-to-brain delive
benzinga.com
Silo Pharma Confirms Nine‑Month Stability Of SPC‑15 Intranasal Prophylactic, Supporting IND‑Enabling
Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling dev